MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer

MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer

Zuo Tao,* Huandan Suo,* Lei Zhang, Zining Jin, Zhen Wang, Danyu Wang, Ming Wu, Nanxi Peng, Yujie Zhao, Bo Chen Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province 110001, People’s Republic of China*These authors contributed equally to t...

Full description

Bibliographic Details
Main Authors: Tao Z, Suo H, Zhang L, Jin Z, Wang Z, Wang D, Wu M, Peng N, Zhao Y, Chen B
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:OncoTargets and Therapy
Subjects:
cancer genome map
breast cancer
mrpl13
clinical significance
Online Access:https://www.dovepress.com/mrpl13-is-a-prognostic-cancer-biomarker-and-correlates-with-immune-inf-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/mrpl13-is-a-prognostic-cancer-biomarker-and-correlates-with-immune-inf-peer-reviewed-article-OTT

Similar Items